1. Home
  2. DARE vs CREX Comparison

DARE vs CREX Comparison

Compare DARE & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • CREX
  • Stock Information
  • Founded
  • DARE N/A
  • CREX N/A
  • Country
  • DARE United States
  • CREX United States
  • Employees
  • DARE N/A
  • CREX N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • CREX EDP Services
  • Sector
  • DARE Health Care
  • CREX Technology
  • Exchange
  • DARE Nasdaq
  • CREX Nasdaq
  • Market Cap
  • DARE 31.9M
  • CREX 28.1M
  • IPO Year
  • DARE N/A
  • CREX N/A
  • Fundamental
  • Price
  • DARE $3.34
  • CREX $2.53
  • Analyst Decision
  • DARE Strong Buy
  • CREX Strong Buy
  • Analyst Count
  • DARE 4
  • CREX 2
  • Target Price
  • DARE $20.33
  • CREX $8.00
  • AVG Volume (30 Days)
  • DARE 37.5K
  • CREX 52.5K
  • Earning Date
  • DARE 11-14-2024
  • CREX 11-13-2024
  • Dividend Yield
  • DARE N/A
  • CREX N/A
  • EPS Growth
  • DARE N/A
  • CREX N/A
  • EPS
  • DARE N/A
  • CREX 0.07
  • Revenue
  • DARE $1,881,316.00
  • CREX $54,300,000.00
  • Revenue This Year
  • DARE N/A
  • CREX $13.37
  • Revenue Next Year
  • DARE $136.52
  • CREX $17.58
  • P/E Ratio
  • DARE N/A
  • CREX $35.39
  • Revenue Growth
  • DARE 88.13
  • CREX 31.80
  • 52 Week Low
  • DARE $2.67
  • CREX $2.39
  • 52 Week High
  • DARE $7.56
  • CREX $5.20
  • Technical
  • Relative Strength Index (RSI)
  • DARE 52.30
  • CREX 39.86
  • Support Level
  • DARE $3.03
  • CREX $2.46
  • Resistance Level
  • DARE $3.38
  • CREX $2.65
  • Average True Range (ATR)
  • DARE 0.12
  • CREX 0.19
  • MACD
  • DARE 0.02
  • CREX 0.01
  • Stochastic Oscillator
  • DARE 88.57
  • CREX 21.31

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to global retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

Share on Social Networks: